Monopar Therapeutics Inc (MNPR) stock news · $431.4M cap
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
This MNPR news page leads with what Monopar Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for MNPR yet. We will not pad this page with generic market recap.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MNPR stock page; for the tape open the quote page.
Not investment advice.